Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atfal Pharma was a Switzerland-based pediatric-focused pharmaceutical company that described itself as dedicated to the development, acquisition, and commercialization of healthcare solutions for children in emerging markets. Publicly available business-directory and company-profile sources consistently describe the company as operating in pediatrics, branded generics, and commercialization rather than as a discovery-stage biotech with a disclosed R&D pipeline. The company appears to have been based in Basel and targeted regions including the Middle East, North Africa, Africa, and parts of Asia-Pacific. Corporate registry data indicate the former company name Atfal Pharma AG was later changed to Alp Medtech AG, suggesting the Atfal Pharma entity/name is no longer operating independently under that brand. Limited reliable public information is available on specific products, development programs, or partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atfal Pharma.